Paradise J L, Bluestone C D, Colborn D K, Bernard B S, Smith C G, Rockette H E, Kurs-Lasky M
Department of Pediatrics, Children's Hospital of Pittsburgh, School of Medicine, University of Pittsburgh, PA 15213-3417, USA.
JAMA. 1999 Sep 8;282(10):945-53. doi: 10.1001/jama.282.10.945.
Adenoidectomy and adenotonsillectomy are commonly performed in US children to reduce the occurrence of persistent or recurrent otitis media, but evidence supporting the efficacy of the operations is limited.
To test the efficacy of adenoidectomy and adenotonsillectomy in children with persistent or recurrent otitis media who had not previously undergone tube placement and to compare the relative efficacy of adenoidectomy alone vs adenotonsillectomy in such children.
Two parallel randomized clinical trials.
A total of 461 children aged 3 to 15 years were enrolled at Children's Hospital of Pittsburgh, Pa, between April 1980 and April 1994. Four hundred ten children were observed for up to 3 years.
Children without recurrent throat infection or tonsillar hypertrophy (304 enrolled; 266 followed up) were randomized to either an adenoidectomy, adenotonsillectomy, or control group; children who had such conditions (157 enrolled; 144 followed up) were randomized to an adenotonsillectomy or control group.
Occurrence rate of episodes of acute otitis media by treatment group and estimated proportion of time with otitis media.
In both trials, most subjects were eligible because of recurrent acute otitis media, with or without persistent otitis media with effusion. A total of 47 children assigned to surgical treatment groups had no surgery. The efficacy of surgery in both trials was modest and limited mainly to the first follow-up year. The largest differences in that year were found in the 3-way trial between the adenotonsillectomy group and the control group: mean annual rate of episodes of acute otitis media, 1.4 vs 2.1 (P<.001); and mean estimated percentage of time with otitis media, 18.6% vs 29.9% (difference, 11.3%; 95% confidence interval, 4.4%-18.2%; P=.002). Perioperative and postoperative complications or other adverse events occurred not infrequently, especially among subjects undergoing adenotonsillectomy (14.6%).
Our study showed limited and short-term efficacy of both adenoidectomy and adenotonsillectomy; given the risks, morbidity, and costs of these procedures, these data suggest that neither operation should ordinarily be considered as a first surgical intervention in children whose only indication is recurrent acute otitis media.
在美国,腺样体切除术和腺样体扁桃体切除术常用于儿童,以减少持续性或复发性中耳炎的发生,但支持这些手术疗效的证据有限。
检验腺样体切除术和腺样体扁桃体切除术对未曾接受过置管治疗的持续性或复发性中耳炎患儿的疗效,并比较单纯腺样体切除术与腺样体扁桃体切除术在这类患儿中的相对疗效。
两项平行随机临床试验。
1980年4月至1994年4月期间,宾夕法尼亚州匹兹堡儿童医院共招募了461名3至15岁的儿童。对410名儿童进行了长达3年的观察。
无复发性咽喉感染或扁桃体肥大的儿童(304名入组;266名接受随访)被随机分为腺样体切除术组、腺样体扁桃体切除术组或对照组;有上述情况的儿童(157名入组;144名接受随访)被随机分为腺样体扁桃体切除术组或对照组。
治疗组急性中耳炎发作的发生率以及中耳炎持续时间的估计比例。
在两项试验中,大多数受试者符合入选标准是因为复发性急性中耳炎,伴有或不伴有持续性中耳积液。共有47名被分配到手术治疗组的儿童未接受手术。两项试验中手术的疗效均一般,且主要局限于首次随访年。在该年最大的差异出现在三项试验中的腺样体扁桃体切除术组与对照组之间:急性中耳炎发作的年均发生率,分别为1.4次和2.1次(P<0.001);中耳炎持续时间的平均估计百分比,分别为18.6%和29.9%(差值为11.3%;95%置信区间为4.4%-18.2%;P=0.002)。围手术期和术后并发症或其他不良事件并不少见,尤其是在接受腺样体扁桃体切除术的受试者中(14.6%)。
我们的研究表明腺样体切除术和腺样体扁桃体切除术的疗效有限且为短期疗效;鉴于这些手术的风险、发病率和成本,这些数据表明,对于唯一指征为复发性急性中耳炎的儿童,通常不应将这两种手术视为首选的外科干预措施。